Advances in Treatment of Hereditary Angioedema

Join hereditary angioedema expert Aleena Banerji, MD, FAAAAI, for a discussion about the diagnosis and management of hereditary angioedema, focusing on treatment developments that have dramatically improved the care of patients with HAE.Continuing Medical Education credit is available with this episode. Visit here to complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s)™Find out more about hereditary angioedema.US Hereditary Angioedema Association 

Diagnosing Food Protein Induced Enterocolitis Syndrome (FPIES) can be challenging and once diagnosed, there are few options for treatment other than strict avoidance and waiting for resolution. Sara Anvari, MD, MSc, FAAAAI, discusses the presentation and pathophysiology of FPIES and how treatment options beyond avoidance are evolving.Continuing Medical Education credit is available with this episode. Visit here to complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s)™FPIES (Food Protein-Induced Enterocolitis Syndrome) Action Plan

How do families know when to give epinephrine and when to go to the ER? How long do we need to observe after an episode of anaphylaxis and who is at risk for recurrent symptoms? We discuss these important questions and more with Tim Dribin, MD, a pediatric emergency medicine physician, who is working to optimize emergency department care for patients with anaphylaxis.Learn more about anaphylaxis.

From now until December 31, 2025, AAAAI Fellows (those who have achieved the FAAAAI credential) and full members will select the next Board of Directors, including the next Secretary-Treasurer who will eventually ascend to become AAAAI President. Secretary-Treasurer candidates Stuart L. Abramson, MD, PhD, AE-C, FAAAAI, and Mariana C. Castells, MD, PhD, FAAAAI, offer their perspective on a series of questions pertaining to their candidacy during this must-listen episode. (November 3, 2025)Access the online voting center.

Advising our families with food allergies as they navigate kids in school, holidays, introduction of foods in siblings, etc., can be challenging. Michael Pistiner, MD, MMSc, joins us to talk about resources we can use to help families introduce new foods and work with schools to help advocate for our patients. He also discusses his food allergy buddy program that allows older kids with food allergies to mentor younger kids to help build their community.Find out more about food allergies.Dietary Guidelines for AmericansBuilding a Healthy Eating Routine for your Baby (Birth to Age 2)Food Allergy Management in Schools (FAMS)

Latex Allergy has become much less common over the past two decades thanks to widespread changes in healthcare practices but still remains essential to recognize when present. Jay Slater, MD, discusses the history of latex allergy as well as how to recognize and test for this in our patients.Find out more about latex allergy. 

Drug allergy expert David Khan, MD, FAAAAI, discusses the importance of evaluating patients with reported penicillin allergy and how allergists can partner with other healthcare providers to make sure all the patients with this label are evaluated. Penicillin Allergy Toolbox

Urticaria expert Sarbjit (Romi) Saini, MD, FAAAAI, discusses new treatments for chronic urticaria, particularly BTK inhibitors. We discuss the recent trials with these medications, including efficacy and safety, as well as other medications on the horizon.Listen to our other podcast episodes. 

Many of us are seeing increasing numbers of patients asking us if they might have a mast cell disorder. How do we diagnose this and what clues will help us know whether or not to pursue this? Join Onyinye Iweala, MD, PhD, FAAAAI, as we discuss Mast Cell Activation Syndrome and how to better understand this confusing disorder. The Mast Cell Disease Society Inc.

AAAAI President Frank Virant, MD, FAAAAI, discusses his career and how the field of allergy/immunology has changed over time. We also chatted about how his presidential initiatives are designed to help patients and allergists, including increasing the visibility of allergy as a specialty, creating living practice parameters and increasing the pipeline into the field.